Stay updated on CDX-585 in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the CDX-585 in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CDX-585 in Advanced Malignancies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the Phase 1 CDX-585 study record, including its completed status, eligibility criteria, study locations, treatment plan, and outcome measures, instead of a 403 error.
    Difference
    57%
    Check dated 2026-10-26T14:36:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:12:14.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:59.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error page, including a basic HTML structure and the 403 message, instead of the previous content. This indicates an access restriction rather than an update to substantive study details.
    Difference
    19%
    Check dated 2026-09-21T20:27:44.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page's revision has been updated from v3.6.5 to v3.6.6. This update appears to be a backend or documentation change to the page and does not alter study data or user-visible content.
    Difference
    0.1%
    Check dated 2026-08-31T17:28:00.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Cholangiocarcinoma has been removed from the Conditions list, and the related topics/MedlinePlus Genetics sections have been deleted. This changes what cancer types the study presents as eligible and removes some patient-facing informational links.
    Difference
    0.2%
    Check dated 2026-08-24T19:10:57.000Z thumbnail image

Stay in the know with updates to CDX-585 in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CDX-585 in Advanced Malignancies Clinical Trial page.